Quest Diagnostics Encourages Denver Area Residents to Enroll in Historic American Cancer Society Prevention Study November 8th - 19th

Quest Diagnostics joined the American Cancer Society today to encourage Denver-area residents to participate in the American Cancer Society's historic Cancer Prevention Study - 3 (CPS-3).  The Denver enrollment period for this national, longitudinal study is between November 8 and 19, 2011. The CPS-3 Study focuses on uncovering the lifestyle, environmental and genetic factors that influence cancer risk by following 300,000 adults over the course of 20 years. The American Cancer Society and Quest Diagnostics are hoping to recruit approximately 1,000 Denver residents into the study.  

"Quest Diagnostics applauds and thanks the American Cancer Society for pursuing the knowledge necessary to fight cancer for future generations, and we are proud to play a role in the important research that will inform that fight," said Laure Park, Vice President Communications and Investor Relations and Corporate Citizenship Officer for Quest Diagnostics. "We encourage Denver area residents to enroll in CPS-3, and join with us in supporting the American Cancer Society as they work to create more birthdays, both today and tomorrow."   Click here to read the original article in its entirety.   ACS18632